Slough, United Kingdom
Lonza is initiating a $25.7 million expansion of its biopharmaceutical manufacturing campus in Slough, U.K. Construction will begin in mid-2011 on a 60,000-sf facility housing process development labs, a fermentation suite, purification suites, and a GMP warehouse. Completion is expected in late 2012.
